Log In
Print this Print this

525762, GSK525762

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionBromodomain inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationEpithelial cancer
Indication DetailsTreat NUT midline carcinoma (NMC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today